19 Mar 2015

Esmeron (Rocuronium bromide) - United Kingdom

ATC: M03AC
MUSCULO-SKELETAL SYSTEM
MUSCLE RELAXANTS
MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
OTHER QUATERNARY AMMONIUM COMPOUNDS
Esmeron

Generic Matches for Rocuronium bromide (1)
Esmeron

Last Updated on 19 Mar 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Esmeron Indication

Esmeron is indicated in adult and paediatric patients (from term neonaotes to adolescents [0 to <18 years]) as an adjunct to general anaesthesia to facilitate tracheal intubation during routine sequence induction and to provide skeletal muscle relaxation during surgery. In adults Esmeron is also indicated to facilitate tracheal intubation during rapid sequence induction and as an adjunct in the intensive care unit (ICU) to facilitate intubation and mechanical ventilation.

 

Esmeron Generic Name

Rocuronium bromide

Type

POM

Summary Product Characteristics (SPCs) Links
Esmeron 10mg/ml solution for injection (external site)

Free Medical Education Resources

Esmeron Marketing Information

Esmeron Generic Name
Rocuronium bromide
Marketing Company
NV Organon
Drug Type
POM
Date of Issue, Marketing Authority 15/07/1996

Related Drugs - Anesthesiology

Back to top